Is Body Weight Loss a Harbinger of Methamphetamine-induced Neurotoxicity?
Year: 2013
Type: article
Abstract: Methamphetamine (MA) is a drug of abuse of societal concern. Euphoria, increased energy/alertness and enhanced libido all contribute to the appeal, and therefore, abuse of this psychostimulant. Weight loss represents still another attribute of MA as indicated in both human [14] and animal [5,6] studies. In fact, weight loss has been reported as a reason for MA use [7-9] and MA under the trademark name Desoxyn, has been approved for use clinically in the treatment of exogenous obesity, as well as for ADHD and narcolepsy [10].
Author: Dean E Dluzen
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W2328504607